We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PRTA market cap is 1.09B. The company's latest EPS is USD -2.7369 and P/E is -7.43.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.52M | 49.92M | 2.17M | 4.02M | 84.87M |
| Operating Income | -50.4M | -72k | -56.33M | -66.5M | 10.06M |
| Net Income | -45.76M | 6.35M | -46.86M | -54.6M | 21.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 814k | 853k | 200.58M | 53.91M | 91.37M |
| Operating Income | -85.76M | -112.73M | 71.98M | -131.56M | -191.04M |
| Net Income | -77.68M | -111.14M | 66.98M | -116.95M | -147.03M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 554.44M | 758.04M | 741.59M | 720.65M | 746.92M |
| Total Liabilities | 149.79M | 135.99M | 134.18M | 138.97M | 129.69M |
| Total Equity | 404.65M | 622.04M | 607.41M | 581.68M | 617.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 419.27M | 332.98M | 609.37M | 758.04M | 696.38M |
| Total Liabilities | 146.35M | 148.97M | 143.32M | 135.99M | 135.02M |
| Total Equity | 272.92M | 184.01M | 466.04M | 622.04M | 561.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -103.85M | -108.82M | -47.46M | -92.39M | -82.87M |
| Investing | -313k | -464k | -48k | -819k | -1.26M |
| Financing | 20.69M | 241.46M | 23.28M | 41.91M | 44.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -52.97M | -80.36M | 92.61M | -108.82M | -133.91M |
| Investing | -547k | -196k | -575k | -464k | -2.77M |
| Financing | 228k | 215k | 190.33M | 241.46M | 45.1M |
| Market Cap | 1.09B |
| Price to Earnings Ratio | -7.43 |
| Price to Sales Ratio | 11.96 |
| Price to Cash Ratio | 1.77 |
| Price to Book Ratio | 1.95 |
| Dividend Yield | - |
| Shares Outstanding | 53.72M |
| Average Volume (1 week) | 449.05k |
| Average Volume (1 Month) | 509.09k |
| 52 Week Change | -61.32% |
| 52 Week High | 79.65 |
| 52 Week Low | 19.65 |
| Spread (Intraday) | 0.8 (3.86%) |
| Company Name | Prothena Corporation PLC |
| Address |
77 sir john rogerson’s quay dublin D02 VK60 |
| Website | https://www.prothena.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
